Variant #0000814822 (NC_000005.9:g.176831232G>T, NM_000505.3:c.983C>A (F12))
Individual ID |
00385745 |
Chromosome |
5 |
Allele |
Unknown |
Affects function (as reported) |
Affects function |
Affects function (by curator) |
Affects function |
Classification method |
ACMG |
Clinical classification |
pathogenic |
DNA change (genomic) (Relative to hg19 / GRCh37) |
g.176831232G>T |
DNA change (hg38) |
g.177404231G>T |
Published as |
- |
ISCN |
- |
DB-ID |
F12_000008 See all 38 reported entries |
Variant remarks |
A single Canadian pedigree with 6 affected female individuals. Affected females have polymorphisms associated with lower levels of both APP and ACE, the major enzymes responsible for bradykinin catabolism. Three patients also carry the A allele of SNP rs3788853 in the XPNPEP2 gene, which may have contributed to the phenotype, making this observation the first one with multiple genes that might contribute to estrogen-dependent or estrogen associated HAE-F12. But this allele is also found in 10 unaffected family members. The c.983C>A variant meets the ACMG criteria to be characterized pathogenic PP1, PM1, PM5, PS3, PS4_Mod |
Reference |
Journal: Duan 2009 |
ClinVar ID |
- |
dbSNP ID |
- |
Origin |
Germline |
Segregation |
yes |
Frequency |
- |
Re-site |
- |
VIP |
- |
Methylation |
- |
Average frequency (gnomAD v.2.1.1) |
Retrieve |
Owner |
Christian Drouet |
Database submission license |
Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International |
Created by |
Christian Drouet |
Date created |
2021-10-14 17:40:10 +02:00 (CEST) |
Date last edited |
2025-02-06 11:25:50 +01:00 (CET) |

Variant on transcripts
Screenings
|